An Automatic Platform Based on Nanostructured Microfluidic Chip for Isolating and Identification of Circulating Tumor Cells

An Automatic Platform Based on Nanostructured Microfluidic Chip for Isolating and Identification of Circulating Tumor Cells

Circulating tumor cell (CTC) test is currently used as a biomarker in cancer treatment. Unfortunately, the poor reproducibility and limited sensitivity with the CTC detection have limited its potential impact on clinical application. A reliable automated CTC detection system is therefore needed. We...

Full description

Bibliographic Details
Main Authors: Hei-Jen Jou, Li-Yun Chou, Wen-Chun Chang, Hsin-Cheng Ho, Wan-Ting Zhang, Pei-Ying Ling, Ko-Hsin Tsai, Szu-Hua Chen, Tze-Ho Chen, Pei-Hsuan Lo, Ming Chen, Heng-Tung Hsu
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Micromachines
Subjects:
circulating tumor cells
epithelial ovarian cancer
liquid biopsy
CD13
SKOV3
Online Access:https://www.mdpi.com/2072-666X/12/5/473

Internet

https://www.mdpi.com/2072-666X/12/5/473

Similar Items